Skip to main content
Clinical Trials/NCT01736384
NCT01736384CompletedNot Applicable

Can Genetic Changes Predict Weight Loss and Outcome After Bariatric Surgery and Can it Related to Virus Infection and Function of Liver and Adipose Tissue as Well as Lipid and Protein Profiles.

Karolinska Institutet3 sites in 1 country2,000 target enrollmentStarted: February 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,000
Locations
3
Primary Endpoint
Genetic markers

Study Overview

Brief Summary

There is a variability in weight loss after gastric bypass surgery for obesity despite a standardised surgical procedure. This study aims to investigate if genetic markers can predict outcome after gastric by-pass surgery in treatment of obesity. The investigators will also study if adenovirus infection can influence the outcome after surgery. In a subgroup of patients, hormonal changes after gastric by-pass surgery will be assessed. Lipid and protein patterns will be assessed in plasma and tissues. Omental and subcutaneous fat as well as liver biopsies and whole blood are stored in a biobank. The same tissues will be collected from non-obese controls undergoing gallbladder surgery.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • laparoscopic gastric by-pass with BMI greater than 35

Exclusion Criteria

  • unable to understand swedish

Outcomes

Primary Outcomes

Genetic markers

Time Frame: day of surgery and 1 and 2 years after surgery

Blood samples and tissue biopsies taken at the time of surgery and at follow-up.

Secondary Outcomes

  • Lipid and protein patterns in plasma and tissues(day of surgery and at 1 and 2 years postoperatively)
  • Genexpression and comorbid disease(At time of bariatric surgery and 1-2 years postoperatively)
  • Previous viral infection(At time of surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erik Näslund

Professor

Karolinska Institutet

Study Sites (3)

Loading locations...

Similar Trials